Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 24, 2022

50715_rns_2022-06-24_fbdb6c18-b75d-413b-a7d3-470ceea9c8b5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

24 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumberof sharesinvolved Totalamount paid/ received Highest (H)prices paid/ received Lowest (L)prices paid/ received
CICC FinancialTrading Limited 23 June2022 Other typesof securities(e.g. equityswaps) Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-driven dealings. Iconfirm this was done no later than theclose of the morning trading session onthe trading day following the orginatingclient-driven dealing Purchase 1,300 $45,559.4000 $35.0457 $35.0457

==> picture [71 x 43] intentionally omitted <==

Public Disclosure Form

Ordinary Closing / flattening / unwinding of Sale 1,300 $45,566.7900 $35.0900 $35.0800
shares proprietary positions arising from
unsolicited client-driven dealings. I
confirm this was done no later than the
close of the morning trading session on
the trading day following the orginating
client-driven dealing

End

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.